secwatch / observer
8-K filed January 3, 2023, 6:59 PM ET ticker CNSP CIK 0001729427
leadership confidence high sentiment neutral materiality 0.35

CNS Pharmaceuticals appoints Faith Charles as independent Chair of Board

CNS Pharmaceuticals, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Faith Charles

Chairperson of the Board of Directors
CNSP · CNS Pharmaceuticals, Inc.
Effective
2022-12-30
Filed
January 3, 2023, 6:59 PM ET
On December 30, 2022, the Board of Directors of CNS Pharmaceuticals, Inc. (the “Company”) appointed Faith Charles as an independent member of the Company’s Board of Directors and as Chairperson of the Board of Directors, effective on such date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Faith Charles was appointed as Chairperson of the Board of Directors at CNS Pharmaceuticals, Inc..

Action
appointed
Role
Chairperson of the Board of Directors
Exact text from the filing
On December 30, 2022, the Board of Directors of CNS Pharmaceuticals, Inc. (the “Company”) appointed Faith Charles as an independent member of the Company’s Board of Directors and as Chairperson of the Board of Directors, effective on such date.
View on SEC.gov

CNS Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR
accession 0001683168-23-000004
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.